First Name:

Last Name:

Address:

E-mail:

Section 1

Section 2

(If you would consider initiating therapy yourself, please go straight to Section 3.)

2.1    Please rate your comfort with the following statements, and your interest in participating in CME programmes on these topics.

2.2    Please think about your recent management of chronic hepatitis B, and consider the following case: A 40-year-old man presents to clinic. He was diagnosed with chronic hepatitis B 5 years previously and advises that he has not received any treatment as his blood tests have always been "normal". Physical examination is unremarkable. What would be your initial management approach?

2.3    The patient returns to clinic. His laboratory tests reveal that he is HBeAg negative, anti HBe positive, has an HBV DNA level of 5,000 IU/mL (25,000 copies/mL); ALT is 45 U/L (previously 30 U/L – upper limit of normal – 30 IU/L) and platelets are 145 x 109/L; hemoglobin, white cell count and INR are within normal range. What would you do now?

2.4    What therapies for patients with chronic hepatitis B are you aware of?

2.5    What aspect of managing patients with chronic hepatitis B do you find the most challenging?

Please go to Section 4.

Section 3

(If you predominately identify and refer patients with chronic hepatitis B, please answer Sections 2 and 4 only.)

3.1    Please provide your assessment of NON-SPECIALISTS' knowledge of the following:

3.2    Please rate YOUR comfort with the following and your interest in participating in CME programmes on these subjects.

3.3    Which first line therapy (i.e., in treatment-naïve patients) have you used in the past?

------ Select one or more by holding down the "Ctrl" key and making your selections ------ Interferon PEG-interferon Lamivudine Adefovir Entecavir Tenofovir Telbivudine Combination therapy

3.4    What do you find is the most challenging aspect of managing patients with chronic hepatitis B?

3.5    In your opinion, are education programmes aimed at improving referral of patients from the community setting needed? If so, what topics would you recommend?

3.6    What recent developments (last 12 months) or anticipated developments could change YOUR management of chronic hepatitis B? How will these developments affect treatment paradigms?

3.7    From where do you obtain your information regarding the management of chronic hepatitis B?

Section Four

4.1    What is your preferred format for LIVE CME/CE events? Please rate the following from 1–7, where 1 is your "first choice".

Symposia at national congresses: --- Select --- 1 2 3 4 5 6 7

Case discussions: --- Select --- 1 2 3 4 5 6 7

Grand rounds presentations
(expert panel/speaker): --- Select --- 1 2 3 4 5 6 7

One-day preceptorship programme: --- Select --- 1 2 3 4 5 6 7

Live webcasts: --- Select --- 1 2 3 4 5 6 7

Evening/dinner meetings: --- Select --- 1 2 3 4 5 6 7

Other (please specify): --- Select --- 1 2 3 4 5 6 7

Other:

4.2    What is your preferred format for ONGOING CME/CE material? Please rate the following from 1–9, where 1 is your "first choice".

Printed monograph: --- Select --- 1 2 3 4 5 6 7 8 9

Printed journal supplement: --- Select --- 1 2 3 4 5 6 7 8 9

Online interactive module: --- Select --- 1 2 3 4 5 6 7 8 9

CD: --- Select --- 1 2 3 4 5 6 7 8 9

PDA/Palm pilot: --- Select --- 1 2 3 4 5 6 7 8 9

Audio (MP3/podcast): --- Select --- 1 2 3 4 5 6 7 8 9

Slide resource: --- Select --- 1 2 3 4 5 6 7 8 9

Archived webcast: --- Select --- 1 2 3 4 5 6 7 8 9

Other (please specify): --- Select --- 1 2 3 4 5 6 7 8 9

Other:

Thank you for your assistance.